Diploma PLC

Diploma PLC

86.65
EUR
-4.45
(-4.88%)
9.25BMarket Cap
Nov 17Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.54
2.71
2.95
3.38
3.99
4.29
4.81
4.75
6.33
8.13
9.26
10.17
11.37
- -
Basic EPS, GAAP
0.31
0.31
0.32
0.34
0.42
0.48
0.55
0.43
0.56
0.76
0.91
0.96
1.38
- -
Free Cash Flow per Basic Share
0.32
0.35
0.37
0.48
0.5
0.52
0.52
0.67
0.88
0.88
1.28
1.33
1.89
- -
Dividend per Share
0.15
0.16
0.17
0.19
0.21
0.24
0.26
0.2
0.43
0.45
0.54
0.57
0.6
- -
Book Value per Share
1.56
1.63
1.67
2.06
2.31
2.57
2.84
4.23
4.31
5.32
6.69
6.63
7.38
7.85
Tangible Book Value per Share
0.63
0.66
0.52
0.55
0.75
0.95
0.6
2.23
-0.58
-1.36
-0.51
-1.22
-0.42
-0.42
Basic Weighted Avg Shares
112
113
113
113
113
113
113
113
124
125
130
134
134
134
Sales/Revenue/Turnover
286
306
334
383
452
485
545
538
787
1,013
1,200
1,363
1,525
- -
Operating Margin (%)
17.06
16.45
15.85
14.48
15.16
15.09
15.44
12.96
13.25
14.25
15.48
15.17
18.69
- -
Depreciation Expense
3
3
4
5
5
5
5
13
21
24
29
32
31
- -
Net Income, GAAP
35
36
37
38
48
54
62
49
70
95
118
129
185
- -
Effective Tax Rate (%)
28.25
27.51
27.8
27.59
27.84
25.17
25.27
25.34
27.85
26.33
23.97
26.39
25.29
- -
Profit Margin (%)
12.08
11.61
10.99
10.01
10.51
11.09
11.36
9.16
8.86
9.35
9.81
9.48
12.13
- -
Working Capital
65
74
80
72
88
106
113
275
117
166
252
318
310
362
LT Debt
- -
- -
20
- -
- -
- -
42
27
227
397
382
539
451
486
Total Equity
178
187
195
238
267
294
325
531
541
668
902
895
994
1,057
Return on Invested Capital (%)
19.51
19.5
18.54
16.91
18.7
18.96
18.45
10.95
10.89
11
11.47
11.05
14.45
- -
Return on Capital (%)
19.8
19.21
18.27
16.56
18.3
18.99
18.74
10.98
10.92
10.72
10.95
10.77
14.01
- -
Return on Common Equity (%)
20.13
19.65
19.63
18.1
19.17
19.45
20.21
11.62
13.13
15.81
15.11
14.5
19.69
- -

Capital Structure

GBP

•

in mil. unless spec.
Mar'25
Sep'25
Mar'26
ST Debt
14
14
15
LT Borrowings
439
380
411
LT Finance Leases
53
70
75
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
134
134
134
Market Capitalization
5,254
7,197
8,087

Working Capital

GBP

•

in mil. unless spec.
Mar'25
Sep'25
Mar'26
Total Current Assets
591
608
705
Cash, Cash Equivalents & STI
65
82
69
Accounts Receivable, Net
225
211
276
Inventories
300
297
360
Total Current Liabilities
254
298
342
Payables & Accruals
- -
- -
- -
ST Debt
14
14
15
Deferred Revenue
- -
- -
- -

Growth Rates

GBP

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
18.91%
14.15%
11.12%
Free Cash Flow
21.21%
29.05%
41.93%
Net Income, GAAP
19.07%
30.88%
43%
Sales/Revenue/Turnover
17%
23.76%
11.82%
Total Cash Common Dividend
19.53%
34.74%
5.08%

Semi-annual Revenue

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1,363
2025
- -
- -
1,525
2026
- -
- -
- -

Semi-annual Earnings Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.96
2025
- -
- -
1.38
2026
- -
- -
- -

Semi-annual Dividends Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.57
2025
- -
- -
0.6
2026
- -
- -
- -

Company Description

CEO
Jonathan David Thomson
Full Time Employees
3,390
Sector
Distribution services
Industry
Wholesale distributors
Address
12 Charterhouse Square London GL United Kingdom EC1M 6EE
IPO Date
Jan 3, 1986
Business
Diploma PLC is a United Kingdom-based decentralized, value-add distributor specializing in critical technical products and services across three core sectors: Controls, Seals, and Life Sciences. The Controls sector offers wire and cables, interconnect solutions, specialty adhesives, specialty fasteners, and industrial automation equipment. The Seals sector provides sealing solutions and fluid power products supporting aftermarket repairs, original equipment manufacturing, and maintenance, repair, and overhaul projects. The Life Sciences segment supplies technology-driven, value-added solutions for in vitro diagnostics, scientific research, and medtech markets. Founded in 1931 and headquartered in London, Diploma operates with a strong international footprint spanning North America, Europe, the United Kingdom, and Australasia, with North America accounting for approximately 62% of group revenue. The company targets specialist end markets including aerospace, defense, datacenters, energy storage, healthcare, and industrial infrastructure. Recent strategic developments over the past two years include a vigorous acquisition program with seven acquisitions since the start of fiscal 2025, notably expanding its aerospace, defense, and in vitro diagnostics (IVD) market presence. Diploma has also invested substantially in innovation, allocating £1.5 million to R&D in 2023, resulting in the launch of three new product lines that enhanced revenue by 20% within six months. Operationally, the company has advanced its technology platform by implementing state-of-the-art inventory and customer relationship management systems, increasing customer engagement and reducing costs by double digits. Financially, it reported record revenues exceeding £1.5 billion in fiscal 2025, reflecting 11% organic growth, driven by strong performances in North America and strategic acquisitions. Adjusted operating margin improved to 22.5%, up 160 basis points, supported by operational leverage and enhanced portfolio quality. Diploma’s business model emphasizes a decentralized structure fostering customer-centricity and agility within specialist markets. Its strategic focus remains on expanding market share in high-growth sectors such as aerospace, defense, datacenters, energy storage, and healthcare, supported by ongoing complementary acquisitions and product extensions. The company’s multidisciplinary product range and geographic diversification underpin its resilient performance amidst evolving market conditions. Diploma PLC continues to leverage its heritage since 1931 and its robust operational capabilities to maintain leadership as a global provider of specialized technical products and value-added services. Diploma PLC’s headquarters are located at 10-11 Charterhouse Square, London, United Kingdom. It employs approximately 3,600 people worldwide and remains committed to sustainable growth and operational excellence through targeted investment in technology and acquisitions. The company’s client base includes original equipment manufacturers, maintenance and repair operators, research institutions, and technology-driven healthcare providers across multiple continents. This profile incorporates the latest financial results, strategic acquisitions, product innovations, and geographic expansion documented through fiscal year 2024 and 2025.